Notice: Temporary Suspension of New Experiment Creation
We have temporarily disabled the creation of new experiments as we are continuously running out of space. This issue has been impacting both uploads and downloads from FlowRepository. By taking this step, we aim to make downloads of existing data more reliable.
We apologize for the inconvenience and appreciate your understanding as we work on upgrading our hardware and improving the overall solution.
Thank you for your patience.

Download-button_s

Experiment Overview

Repository ID: FR-FCM-ZY3S Experiment name: ENUMERATION OF WT1-SPECIFIC CD8+ T CELLS MIFlowCyt score: 46.94%
Primary researcher: Sarah Matko PI/manager: Sarah Matko Uploaded by: Sarah Matko
Experiment dates: 2012-02-28 - 2016-09-15 Dataset uploaded: Mar 2017 Last updated: Jun 2017
Keywords: [Wilms’ tumor antigen (WT1)] [antigen-specific CD8+ T cells] [MHC Streptamer] [singleplatform] Manuscripts: [28544366] Cytalogo
Organizations: None
Purpose: The advent of novel strategies to generate leukemia-associated-antigen (LAA)-specific T cells for adoptive immunotherapies creates a demand for standardized good laboratory practice (GLP)-compliant enumeration assays to provide a secure clinical environment - whether it is to identify potential donors, define therapeutic doses for transplantation or monitor clinical success. Here, we introduce a no-wash assay based on single-platform cell enumeration and Streptamer staining to determine the Wilms? tumor antigen 1 (WT1)-specific T cell immunity in clinical samples.
Conclusion: The accuracy of the assay was high for all performed experiments. Differences were apparent regarding the limit of detection/quantification (LOD/LOQ). Results obtained for WT1 yielded a notably higher LOD/LOQ than for virus-specific multimers. However, subsequent screening of 22 healthy individuals revealed significantly higher values staining for WT1 than for HIV pol-specific T cells. These differences could not be observed applying a classical wash-protocol. Therefore, we strongly suggest the use of no-wash single-platform assays in combination with MHC Streptamer staining for the detection of low affinity T cells.
Comments: None
Funding: This work was supported by a grant from the Bundesministerium fuer Bildung und Forschung (BMBF) - (joint project: Streptamer-based selection of leukemia-specific T cells for adoptive cellular therapy after stem cell transplantation [Stratos], grant no.: 01GU1108A).
Quality control: Triplicates, Limit of detection, limit of quantification, goodness of fit, recovery, linearity, intra-assay-deviation, inter-assay-deviation
Download FCS Files or login and see the dataset in your inbox for further annotation details.